Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Birch polypore (Piptoporus betulinus) has a history of use in traditional medicine, but there is also some emerging scientific evidence suggesting antibacterial activity, including against Staphylococcus species. Laboratory studies have demonstrated that extracts from birch polypore possess antimicrobial properties, likely due to compounds such as piptamine and polyporenic acids. For example, in vitro research has shown that these extracts can inhibit the growth of Staphylococcus aureus, including some resistant strains. However, most of these studies are preliminary, conducted in petri dishes (in vitro) rather than in living organisms (in vivo), and typically use concentrations of extract that may not be achievable or safe in humans.

While these findings are promising, there is currently a lack of robust clinical trials or human studies confirming the effectiveness or safety of birch polypore extracts for treating or supporting staph infections. The evidence base is limited, and there is a significant gap between laboratory results and clinical application. Therefore, although there is some scientific validation of antibacterial effects, the strength of evidence is modest and not sufficient to recommend birch polypore as a primary or adjunct therapy for staph infections in medical practice at this time.

More about Birch polypore
More about Staph Infections

Other ingredients used for Staph Infections

Other health conditions supported by Birch polypore

Products containing Birch polypore